Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Keloids - Overview
Keloids - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Keloids - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Keloids - Companies Involved in Therapeutics Development
CellionBioMed Inc
FirstString Research Inc
Lemonex Inc
Next Science Ltd
siRgen Therapeutics Corp
Siromics Inc
Thiro Bio Inc
Topadur Pharma AG
Tumorend LLC
Viridian Therapeutics Inc
Yuhan Corp
Keloids - Drug Profiles
Antisense Ri Oligonucleotide to Inhibit Amphiregulin for Hypertrophied scar and Keloid - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CBM-C1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CM-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Keloids - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FBM-5712 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Granexin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LEM-S401 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remlarsen - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
STP-705 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TOPN-44 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YHC-1113 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Keloids - Dormant Projects
Keloids - Discontinued Products
Keloids - Product Development Milestones
Featured News & Press Releases
Jul 14, 2021: Siromics doses first patient in phase 2 study of STP705 for keloid scar prevention
Apr 18, 2021: Siromics initiates phase 2 study using STP705 for keloid scar prevention
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Keloids, 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Keloids, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Keloids - Pipeline by CellionBioMed Inc, 2021
Keloids - Pipeline by FirstString Research Inc, 2021
Keloids - Pipeline by Lemonex Inc, 2021
Keloids - Pipeline by Next Science Ltd, 2021
Keloids - Pipeline by siRNAgen Therapeutics Corp, 2021
Keloids - Pipeline by Sirnaomics Inc, 2021
Keloids - Pipeline by Thirona Bio Inc, 2021
Keloids - Pipeline by Topadur Pharma AG, 2021
Keloids - Pipeline by Tumorend LLC, 2021
Keloids - Pipeline by Viridian Therapeutics Inc, 2021
Keloids - Pipeline by Yuhan Corp, 2021
Keloids - Dormant Projects, 2021
Keloids - Discontinued Products, 2021